MicroPort Scientific Corporation
MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, Europe, Middle East and Africa, Japan, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related del… Read more
MicroPort Scientific Corporation (MCRPF) - Net Assets
Latest net assets as of June 2025: $1.18 Billion USD
Based on the latest financial reports, MicroPort Scientific Corporation (MCRPF) has net assets worth $1.18 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.77 Billion) and total liabilities ($2.59 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.18 Billion |
| % of Total Assets | 31.29% |
| Annual Growth Rate | 22.17% |
| 5-Year Change | -17.52% |
| 10-Year Change | 260.21% |
| Growth Volatility | 107.32 |
MicroPort Scientific Corporation - Net Assets Trend (2009–2024)
This chart illustrates how MicroPort Scientific Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MicroPort Scientific Corporation (2009–2024)
The table below shows the annual net assets of MicroPort Scientific Corporation from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.14 Billion | -18.40% |
| 2023-12-31 | $1.40 Billion | -21.74% |
| 2022-12-31 | $1.79 Billion | -19.16% |
| 2021-12-31 | $2.22 Billion | +59.77% |
| 2020-12-31 | $1.39 Billion | +112.24% |
| 2019-12-31 | $653.97 Million | +23.64% |
| 2018-12-31 | $528.95 Million | +20.36% |
| 2017-12-31 | $439.45 Million | +26.83% |
| 2016-12-31 | $346.48 Million | +9.01% |
| 2015-12-31 | $317.83 Million | -7.54% |
| 2014-12-31 | $343.74 Million | -11.93% |
| 2013-12-31 | $390.31 Million | +5.02% |
| 2012-12-31 | $371.67 Million | +10.44% |
| 2011-12-31 | $336.54 Million | +13.27% |
| 2010-12-31 | $297.12 Million | +423.28% |
| 2009-12-31 | $56.78 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MicroPort Scientific Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 159594811000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $17.99K | 0.00% |
| Other Comprehensive Income | $1.51 Billion | 251.15% |
| Other Components | $684.16 Million | 113.42% |
| Total Equity | $603.22 Million | 100.00% |
MicroPort Scientific Corporation Competitors by Market Cap
The table below lists competitors of MicroPort Scientific Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Oculis Holding AG
IC:OCS
|
$944.65 Million |
|
Okinawa Cellular Telephone Company
PINK:OKCTF
|
$945.49 Million |
|
Vienna Insurance Group AG
PINK:VNRGF
|
$945.82 Million |
|
Fastighets AB Balder Series B
LSE:0H2Z
|
$946.63 Million |
|
SVG Optronics Co Ltd
SHE:300331
|
$944.43 Million |
|
Magellan Financial Group Limited
PINK:MGLLF
|
$944.26 Million |
|
Seers Technology
KQ:458870
|
$944.23 Million |
|
North Chemical Industries Co Ltd
SHE:002246
|
$943.98 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MicroPort Scientific Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 757,819,000 to 603,219,424, a change of -154,599,576 (-20.4%).
- Net loss of 214,917,375 reduced equity.
- Share repurchases of 39,787,874 reduced equity.
- Other comprehensive income increased equity by 54,311,596.
- Other factors increased equity by 80,215,077.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-214.92 Million | -35.63% |
| Share Repurchases | $39.79 Million | -6.6% |
| Other Comprehensive Income | $54.31 Million | +9.0% |
| Other Changes | $80.22 Million | +13.3% |
| Total Change | $- | -20.40% |
Book Value vs Market Value Analysis
This analysis compares MicroPort Scientific Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.98x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 19.70x to 2.98x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | $0.05 | $0.98 | x |
| 2010-12-31 | $0.24 | $0.98 | x |
| 2011-12-31 | $0.23 | $0.98 | x |
| 2012-12-31 | $0.26 | $0.98 | x |
| 2013-12-31 | $0.27 | $0.98 | x |
| 2014-12-31 | $0.24 | $0.98 | x |
| 2015-12-31 | $0.22 | $0.98 | x |
| 2016-12-31 | $0.23 | $0.98 | x |
| 2017-12-31 | $0.27 | $0.98 | x |
| 2018-12-31 | $0.28 | $0.98 | x |
| 2019-12-31 | $0.31 | $0.98 | x |
| 2020-12-31 | $0.63 | $0.98 | x |
| 2021-12-31 | $0.82 | $0.98 | x |
| 2022-12-31 | $0.62 | $0.98 | x |
| 2023-12-31 | $0.42 | $0.98 | x |
| 2024-12-31 | $0.33 | $0.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MicroPort Scientific Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -35.63%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -20.76%
- • Asset Turnover: 0.28x
- • Equity Multiplier: 6.02x
- Recent ROE (-35.63%) is below the historical average (-4.81%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 48.07% | 33.24% | 0.79x | 1.84x | $21.62 Million |
| 2010 | 12.18% | 32.99% | 0.33x | 1.10x | $6.49 Million |
| 2011 | 15.17% | 38.20% | 0.36x | 1.11x | $17.40 Million |
| 2012 | 15.26% | 38.02% | 0.35x | 1.15x | $19.54 Million |
| 2013 | 6.28% | 15.82% | 0.30x | 1.33x | $-14.52 Million |
| 2014 | -17.37% | -16.74% | 0.38x | 2.75x | $-93.69 Million |
| 2015 | -3.87% | -3.22% | 0.51x | 2.35x | $-43.34 Million |
| 2016 | 4.25% | 3.63% | 0.50x | 2.33x | $-19.15 Million |
| 2017 | 4.69% | 4.24% | 0.49x | 2.25x | $-21.34 Million |
| 2018 | 5.40% | 3.57% | 0.53x | 2.88x | $-20.37 Million |
| 2019 | 5.59% | 3.66% | 0.50x | 3.08x | $-22.89 Million |
| 2020 | -16.96% | -29.48% | 0.26x | 2.19x | $-304.05 Million |
| 2021 | -18.55% | -35.51% | 0.18x | 2.94x | $-425.56 Million |
| 2022 | -38.46% | -51.91% | 0.21x | 3.52x | $-550.02 Million |
| 2023 | -63.03% | -50.24% | 0.24x | 5.19x | $-553.41 Million |
| 2024 | -35.63% | -20.76% | 0.28x | 6.02x | $-275.24 Million |
Industry Comparison
This section compares MicroPort Scientific Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MicroPort Scientific Corporation (MCRPF) | $1.18 Billion | 48.07% | 2.20x | $944.57 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |